Search results
Results from the WOW.Com Content Network
A 1985 National Research Council report entitled Injury in America [2] recommended that United States Congress establish a new program at the CDC to address the problem of injury. Initially the program was supported with funds from the United States Department of Transportation. In 1990 Congress passed the Injury Control Act which authorized ...
In the specific case, Arthrex, Inc., a manufacturer of medical devices, had previously received a patent for a surgical device. They entered into a patent dispute with Smith & Nephew, Inc. and ArthroCare Corp., claiming the latter groups were infringing on their patent. The case moved into the PTAB, which found that Arthrex's patent was invalid.
She is the Chief Medical Officer and Deputy Director for Program and Science of the Centers for Disease Control and Prevention (CDC). She previously served as the acting Principal Deputy Director (2021-2023) and the Director of the National Center for Injury Prevention and Control (2014-2021).
The U.S. Preventive Services Task Force released a draft recommendation advising against using vitamin D to prevent falls and fractures in people over 60. Pharmacist Katy Dubinsky weighs in.
Later, [when?] the company was renamed as Arthrex Inc. Arthrex distributes its products to more than 90 countries worldwide. It has subsidiaries throughout Europe, including Germany, Austria, Belgium, England and France. [6] In 1991, the headquarters shifted to Naples, Florida. Since then, the company has grown from two employees to over 2000.
The 2000 Simpsonwood CDC conference (officially titled Scientific Review of Vaccine Safety Datalink Information) was a two-day meeting convened in June 2000 by the Centers for Disease Control and Prevention (CDC), held at the Simpsonwood Methodist retreat and conference center in Gwinnett County near Norcross, Georgia.
ACIP statements are official federal recommendations for the use of vaccines and immune globulins in the U.S., and are published by the CDC. ACIP reports directly to the CDC director, although its management and support services are provided by CDC's National Center for Immunization and Respiratory Diseases. [1]
The Connaught Medical Research Laboratories was a non-commercial public health entity established by Dr. John G. FitzGerald in 1914 in Toronto to produce the diphtheria antitoxin. Contemporaneously, the institution was likened to the Pasteur Institutes in France and Belgium and the Lister Institute in London.